Baricitinib Maintains Established Safety Profile - MD Magazine

Baricitinib Maintains Established Safety Profile  MD Magazine

Assorted trials and a long-term exposure study of 3770 patients with rheumatoid arthritis further demonstrate baricitinib's previously recorded safety profile.



Comments

Popular posts from this blog

Epidemiology and prevention of venous thromboembolism

Deep Vein Thrombosis (DVT): Symptoms, Treatment, & More